Correlation Between TG Therapeutics and Treatt Plc

Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Treatt Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Treatt Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TG Therapeutics and Treatt plc, you can compare the effects of market volatilities on TG Therapeutics and Treatt Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Treatt Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Treatt Plc.

Diversification Opportunities for TG Therapeutics and Treatt Plc

-0.34

Correlation Coefficient

TG Therapeutics  Treatt Plc

Very good diversification

The 3 months correlation between TGTX and Treatt is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Treatt plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Treatt plc and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Treatt Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Treatt plc has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Treatt Plc go up and down completely randomly.

Pair Corralation between TG Therapeutics and Treatt Plc

Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.13 times more return on investment than Treatt Plc. However, TG Therapeutics is 1.13 times more volatile than Treatt plc. It trades about 0.14 of its potential returns per unit of risk. Treatt plc is currently generating about 0.05 per unit of risk. If you would invest  2,333  in TG Therapeutics on September 26, 2024 and sell it today you would earn a total of  883.00  from holding TG Therapeutics or generate 37.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

TG Therapeutics  vs.  Treatt plc

TG Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Treatt plc

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Treatt plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Treatt Plc may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with TG Therapeutics and Treatt Plc

The main advantage of trading using opposite TG Therapeutics and Treatt Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Treatt Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Treatt Plc will offset losses from the drop in Treatt Plc's long position.

The idea behind TG Therapeutics and Treatt plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.